IP Library Granted Patent US 10,444,239
Granted Patent B2
US 10,444,239 · App. 15/147,960 · Granted Oct 15, 2019

Methods for measuring carcinoembryonic antigen

Inventors: Sydney David Finkelstein (Pittsburgh, PA); Sara Ann Jackson (Pittsburgh, PA); Jamie Michelle Bleicher (Butler, PA); Eric Matthew Gayle Ellsworth (Pittsburgh, PA); Dennis Morgan Smith, Jr. (St. Augustine, FL)
Assignee: INTERPACE DIAGNOSTICS CORPORATION
G01N33/57473
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,444,239
App. No.
15/147,960
Granted
Oct 15, 2019
Kind
B2
Abstract

Disclosed herein are methods of accurately measuring carcinoembryonic antigen in a biological sample and methods of identifying and treating a mucinous cyst in a subject.

Claims (14)

1. A method of measuring carcinoembryonic antigen in a biological sample, the method comprising:

diluting the biological sample with a diluent at a ratio of biological sample to diluent of about 1:10 to about 1:50 to form a diluted biological sample;

measuring the amylase level of the diluted biological sample; and

measuring carcinoembryonic antigen level in the diluted biological sample,

wherein the measured carcinoembryonic antigen amount is not adjusted with a correction factor.

2. The method of claim 1 , wherein the diluent is saline, Diluent Universal, or a combination thereof.

3. The method of claim 1 , wherein the biological sample is undiluted prior to the diluting step.

4. The method of claim 1 , wherein diluting the biological sample with a diluent comprises diluting the biological sample with a diluent in a ratio of about 1:10.

5. The method of claim 1 , wherein diluting the biological sample with a diluent comprises diluting the biological sample with a diluent in a ratio of about 1:40.

6. The method of claim 1 , wherein the biological sample is not present in sufficient volume to accurately measure carcinoembryonic antigen level prior to the diluting step.

7. The method of claim 1 , wherein the biological sample has a high viscosity prior to the diluting step.

8. The method of claim 7 , wherein the high viscosity is due to the presence of mucin in the biological sample.

9. The method of claim 1 , wherein the carcinoembryonic antigen levels in the biological sample exceed the measurement capabilities of an instrument being used to measure carcinoembryonic antigen level prior to the diluting step.

10. The method of claim 1 , wherein the biological sample is selected from pancreatic fluid, pancreatic cyst fluid and combinations thereof.

Assignments (9)
SECURITY INTEREST Recorded Nov 2, 2021
From: INTERPACE BIOSCIENCES, INC.; INTERPACE DIAGNOSTICS CORPORATION; INTERPACE DIAGNOSTICS, LLC; INTERPACE PHARMA SOLUTIONS, INC.
To: BROADOAK FUND V, L.P.
Reel/Frame 057988/0110 →
SECURITY INTEREST Recorded Oct 20, 2021
From: INTERPACE DIAGNOSTICS CORPORATION
To: COMERICA BANK
Reel/Frame 057851/0289 →
RELEASE OF SECURITY INTEREST Recorded Jun 16, 2017
From: HUDSON BAY MASTER FUND LTD
To: INTERPACE DIAGNOSTICS CORPORATION
Reel/Frame 042858/0971 →
RELEASE OF SECURITY INTEREST Recorded Jun 16, 2017
From: HUDSON BAY MASTER FUND LTD
To: INTERPACE DIAGNOSTICS GROUP, INC.; INTERPACE BIOPHARMA, LLC; INTERPACE DIAGNOSTICS, LLC; INTERPACE DIAGNOSTICS LAB, INC.; INTERPACE DIAGNOSTICS CORPORATION
Reel/Frame 042840/0860 →
RELEASE OF SECURITY INTEREST Recorded Jun 16, 2017
From: HUDSON BAY MASTER FUND LTD
To: INTERPACE DIAGNOSTICS GROUP, INC.; INTERPACE DIAGNOSTICS, LLC; INTERPACE DIAGNOSTICS CORPORATION
Reel/Frame 042856/0799 →
RELEASE OF SECURITY INTEREST Recorded Jun 16, 2017
From: HUDSON BAY MASTER FUND LTD
To: INTERPACE DIAGNOSTICS CORPORATION
Reel/Frame 042856/0895 →
SECURITY INTEREST Recorded Mar 27, 2017
From: INTERPACE DIAGNOSTICS GROUP, INC.
To: HUDSON BAY MASTER FUND LTD
Reel/Frame 041754/0517 →
MERGER AND CHANGE OF NAME Recorded Dec 20, 2016
From: REDPATH INTEGRATED PATHOLOGY, INC.; INTERPACE DIAGNOSTICS CORPORATION
To: INTERPACE DIAGNOSTICS CORPORATION
Reel/Frame 041033/0380 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 20, 2016
From: FINKELSTEIN, SYDNEY DAVID; JACKSON, SARA ANN; BLEICHER, JAMIE MICHELLE; ELLSWORTH, ERIC MATTHEW GAYLE; SMITH, DENNIS MORGAN
To: REDPATH INTEGRATED PATHOLOGY, INC.
Reel/Frame 040683/0056 →
Continuity (5)
Continuation 14092036 · Nov 27, 2013
Provisional Application 61731725 · Nov 30, 2012
Provisional Application 61824623 · May 17, 2013
Provisional Application 61840963 · Jun 28, 2013
Related Publication 20170089907A1 · Mar 30, 2017